Download interactions: TXT MITAB-2.5
| Interaction | Interactor | Experiments | Homologs | Category | Interaction Score |
Confidence |
|---|---|---|---|---|---|---|
|
MLC1
Myosin light chain alkali |
1 |
17 |
High-throughput |
0.618 | High |
|
|
ACTN
Alpha-actinin, sarcomeric |
1 |
4 |
High-throughput |
0.618 | High |
|
|
MLR
Myosin regulatory light chain 2 |
1 |
20 |
High-throughput |
0.618 | High |
|
|
TNNT
Troponin T, skeletal muscle |
1 |
1 |
High-throughput |
0.618 | High |
|
|
Q8MSI2
GH15296p |
1 |
0 |
High-throughput |
0.586 | High |
|
|
MYSA
Myosin heavy chain, muscle |
1 |
1 |
High-throughput |
0.553 | High |
|
|
TNNI
Troponin I |
1 |
10 |
High-throughput |
0.553 | High |
|
|
Q6NL58
LD45673p |
1 |
2 |
High-throughput |
0.439 | High |
|
|
M9NHC5
Uncharacterized protein, isoform C |
1 |
1 |
High-throughput |
0.437 | High |
|
|
ACT4
Actin, larval muscle |
1 |
4 |
High-throughput |
0.437 | High |
|
|
TPM2
Tropomyosin-2 |
1 |
1 |
High-throughput |
0.437 | High |
|
|
GPDA
Glycerol-3-phosphate dehydrogenase [NAD(+)], cytoplasmic |
1 |
1 |
High-throughput |
0.437 | High |
|
|
MYSP2
Paramyosin, short form |
1 |
2 |
High-throughput |
0.437 | High |
|
|
Q8I062
GH23305p |
1 |
1 |
High-throughput |
0.437 | High |
|
|
Q9VIE8
Aconitate hydratase, mitochondrial |
1 |
2 |
High-throughput |
0.437 | High |
|
|
Q9VM18
Trehalose 6-phosphate phosphatase |
1 |
1 |
High-throughput |
0.437 | High |
|
|
Q9VSA9
CG7409 |
1 |
1 |
High-throughput |
0.437 | High |
|
|
CISY
Probable citrate synthase, mitochondrial |
1 |
1 |
High-throughput |
0.437 | High |
|
|
Q9VPA2
Protein hunchback |
1 |
1 |
High-throughput |
0.417 | High |
|
|
ADH
Alcohol dehydrogenase |
1 |
0 |
High-throughput |
0.249 | Low |
|
|
ALF
Fructose-bisphosphate aldolase |
1 |
0 |
High-throughput |
0.249 | Low |
|
|
KARG
Arginine kinase 1 |
1 |
0 |
High-throughput |
0.249 | Low |
|
|
Q9VP84
IP06402p |
1 |
0 |
High-throughput |
0.249 | Low |
|
|
NPLP2
Neuropeptide-like 2 |
1 |
0 |
High-throughput |
0.249 | Low |
Service provided by Combinatics, Japan
Last updated: 15 Jul 2024
